Summary
The pharmacokinetics and haemodialysis clearance of metronidazole were investigated in four renal failure patients after a single 500 mg intravenous dose and in two renal failure patients on continuous treatment with metronidazole. During dialysis, the volume of distribution of metronidazole was 0.60±0.04 l/kg, total clearance was 196.0±60.6 ml/min and the elimination half-life had an harmonic mean of 2.14 h. Extraction across the dialyser was 51.5±7.8% and was limited to the distribution of drug in plasma water. Dialysis clearance was 125.0±32.7 ml/min, which represented 62±6% of total clearance and was 1.75 times the sum of the other clearance mechanisms. The hydroxy metabolite was extracted and cleared by the dialyser to the same degree as metronidazole itself. During the 4 h-dialysis 44.9±2.6% of the dose was removed by the dialyser in the four patients administered a single dose. Metronidazole is efficiently cleared and extensively removed by dialysis, and therefore dosage adjustments and alterations in the timing of dosage administration are essential in patients undergoing haemodialysis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartlett JG (1982) Anti-anaerobic antibacterial drugs. Lancet 2:478–481
Brogden RN, Heel RC, Speight TM, Avery GS (1978) Metronidazole in anaerobic infections: A review of its activity, pharmacokinetics and therapeutic use. Drugs 16:387–417
Cerat GA, Cerat LL, McHenry MC, Wagner JG, Hall PM, Gavan TL (1976) Metronidazole in renal failure. In: Finegold S, McFadzean JA, Rowe FJC (eds) Metronidazole: Proceedings of the International Metronidazole Conference, Montreal. 26–28 May, 1976. International Congress Series No 438. Excerpta Medica, Amsterdam, pp 404–414
Daniel WW (1978) Applied non-parametric statistics. Houghton Mifflin, Boston
Ehrnebo M, Agurell S, Boreus LO, Gordon E, Lonroth U (1974) Pentazocine binding to blood cells and plasma proteins. Clin Pharmacol Ther 16:424–429
Gabriel R, Page CM, Weller IVD, Collier J, Houghton GW, Templeton R, Thorne PS (1979) The pharmacokinetics of metronidazole in patients with chronic renal failure. In: Philips I, Collier J (eds) Metronidazole: Proceedings of the 2nd International Symposium on Anaerobic Infections, Geneva, 25–27 April, 1979. International Congress and Symposium Series No 18. Royal Society of Medicine, London, pp 35–40
Gibson TP, Matusik E, Nelson LD, Briggs WA (1976) Artificial kidneys and clearance calculations. Clin Pharmacol Ther 20:720–726
Goldman P (1980) Metronidazole. New Engl J Med 303:1212–1218
Gotch FA (1976) Hemodialysis: Technical and kinetic considerations. In: Brenner BM, Rector FC (eds) The kidney. Saunders, Philadelphia, pp 1672–1704
Houghton GW, Thorne PS, Smith J, Templeton R, Collier J (1979) Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose. Br J Clin Pharmacol 8:337–341
Kaye CM, Sankey ME, Thomas LA (1980) A rapid and specific semi-micro method involving high-pressure liquid chromatography for the assay of metronidazole in plasma, saliva, serum, urine and whole blood. Br J Clin Pharmacol 9:528–529
Lee CS, Marbury TC, Benet LZ (1980) Clearance calculations in hemodialysis: Application to blood, plasma and dialysate measurements for ethambutol. J Pharmacokinet Biopharm 8:69–81
Levy G (1977) Pharmacokinetics in renal disease. Am J Med 62:461–465
Marques RA, Stafford B, Flynn N, Sadee W (1978) Determination of metronidazole and misonidazole and their metabolites in plasma and urine by high-performance liquid chromatography. J Chromatogr 146:163–166
Somogyi A, Kong CB, Gurr FW, Sabto J, Spicer WJ, McLean AJ (1983) Metronidazole pharmacokinetics in patients with acute renal failure. J Antimicrob Chemother (in press)
Wang LG, Lee CS, Majeske BL, Marbury TC (1981) Clearance and recovery calculations in hemodialysis: Application to plasma, red blood cell, and dialysate measurements for cyclophosphamide. Clin Pharmacol Ther 29:365–372
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Somogyi, A., Kong, C., Sabto, J. et al. Disposition and removal of metronidazole in patients undergoing haemodialysis. Eur J Clin Pharmacol 25, 683–687 (1983). https://doi.org/10.1007/BF00542359
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542359